 Antibodies, Viral
"Antibodies, Viral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Immunoglobulins produced in response to VIRAL ANTIGENS.
| Descriptor ID |
D000914
|
| MeSH Number(s) |
D12.776.124.486.485.114.254 D12.776.124.790.651.114.254 D12.776.377.715.548.114.254
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antibodies, Viral".
Below are MeSH descriptors whose meaning is more specific than "Antibodies, Viral".
This graph shows the total number of publications written about "Antibodies, Viral" by people in this website by year, and whether "Antibodies, Viral" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 | | 1997 | 0 | 4 | 4 | | 1998 | 2 | 3 | 5 | | 1999 | 2 | 3 | 5 | | 2000 | 1 | 0 | 1 | | 2001 | 2 | 4 | 6 | | 2002 | 0 | 2 | 2 | | 2003 | 2 | 6 | 8 | | 2004 | 1 | 6 | 7 | | 2005 | 2 | 4 | 6 | | 2006 | 3 | 5 | 8 | | 2007 | 5 | 6 | 11 | | 2008 | 2 | 7 | 9 | | 2009 | 2 | 11 | 13 | | 2010 | 2 | 5 | 7 | | 2011 | 6 | 3 | 9 | | 2012 | 6 | 4 | 10 | | 2013 | 4 | 4 | 8 | | 2014 | 4 | 7 | 11 | | 2015 | 9 | 6 | 15 | | 2016 | 2 | 7 | 9 | | 2017 | 5 | 14 | 19 | | 2018 | 6 | 13 | 19 | | 2019 | 9 | 10 | 19 | | 2020 | 13 | 16 | 29 | | 2021 | 23 | 27 | 50 | | 2022 | 3 | 38 | 41 | | 2023 | 0 | 13 | 13 | | 2024 | 9 | 16 | 25 | | 2025 | 14 | 13 | 27 | | 2026 | 4 | 2 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Antibodies, Viral" by people in Profiles.
-
Silva MVM, Ximenes RAA, Filho DBM, Martelli CMT, de Araújo TVB, Brickley E, Fontes JMSSA, Fulco GRN, Sá ACCL, Cordeiro MT, Castanha PMDS, Dos Santos Oliveira PA, Montarroyos UR. Kinetics of neutralizing and binding antibody responses following Zika virus infection during pregnancy: A nested analysis of participants from the microcephaly epidemic research group (MERG) and Zika in infants and pregnancy (ZIP) cohorts. Virus Res. 2026 Jun; 368:199725.
-
Bauer RA, Yang Z, Petriello M, Zhang S, Stapleton HM, Adgate JL, Carignan CC. Associations of serum PFAS with COVID-19 antibody levels among fully vaccinated adults. Environ Res. 2026 Jun 01; 298:124154.
-
Hawkins JA, Curtis JR, Weinberg A, Siegel SAR, Huffstutter JE, Loveless J, Gharib S, Reddy S, Sinha J, Ridley D, Messaoudi I, Park JK, Lee EB, Winthrop KL. Safety and immunogenicity of the recombinant zoster vaccine in patients with rheumatoid arthritis using abatacept: a pilot multicentre, double-blind, randomised controlled trial. Ann Rheum Dis. 2026 May; 85(5):787-796.
-
Roubinian NH, Plimier C, Spencer BR, Bravo M, Custer B, D'Alessandro A, Kleinman S, Norris PJ, Busch MP. Transfusion requirements in recipients of plasma units from blood donors with recent SARS-CoV-2 infection. Transfusion. 2026 Apr; 66(4):651-655.
-
Kpetigo AD, Alexandre M, Camara A, Beavogui A, Doumbia S, Kieh M, Leigh B, Sow S, Wittkop L, Soutthiphong AA, Berry IM, Fleck S, Akoo P, Hamze B, Watson-Jones D, Kuhn JH, Greenwood B, Richert L, Yazdanpanah Y, Lévy Y, Thiébaut R, Prague M, Lhomme E. Effect of the time of day for vaccination on the immune response to Ebola Virus Disease vaccines: A modeling study from PREVAC randomized trial. PLoS Negl Trop Dis. 2026 Jan; 20(1):e0013950.
-
Ustianowski A, Levin MJ, De Wit S, Launay O, Veekmans B, Rampling T, Sullivan JG, Vishnepolsky M, Wijewardane P, Fawadleh Y, Zhang H, Li M, Wickramarachchi D, Sharbaugh A, Beavon R, Thissen J, Hirao L, Dzutseva V, Seegobin S, Streicher K, Kiazand A, Esser MT, Chang LJ, Perez JL, Cohen TS. Safety and Pharmacokinetics of Repeat Dosing of Long-Acting SARS-CoV-2 Antibodies Tixagevimab/Cilgavimab (AZD7442): Results from the PROVENT Sub-study. Clin Drug Investig. 2026 Feb; 46(2):207-219.
-
Toews E, Shaikh S, Akter S, Zhang C, Selemon A, Arora RK, Bobrovitz N, Jaenisch T, Ware H, Whelan MG. Serological and viral prevalence of Oropouche virus (OROV): A systematic review and meta-analysis from 2000-2024 including human, animal, and vector surveillance studies. PLoS Negl Trop Dis. 2025 Dec; 19(12):e0013340.
-
Muthuraman K, Jackman M, Liang Y, Garrett ME, Cui H, Nguyen LVH, Ivanochko D, Ye C, Pino PA, Hicks A, Maingot B, Yusko E, Benzeno S, Martínez-Sobrido L, Torrelles JB, Gilbert AE, Rubin BER, Keitany G, Jetha A, Julien J-P. Human antibody targeting of coronavirus spike S2 subunit is associated with protection mediated by Fc effector functions. J Virol. 2025 12 23; 99(12):e0152325.
-
Chiu CY, Chesdachai S, Beam E, Henao-Martínez AF. Seroprevalence and Incidence of Measles, Mumps, and Rubella in Adult Solid Organ Transplant Recipients in the United States: A Large Database Analysis. Transplantation. 2026 Feb 01; 110(2):e464-e471.
-
Chandrasekaran P, Berry IM, Callier V, Anthony SM, Hensley K, Kuhn JH, Shaw-Saliba K, Kennedy SB, Kieh M, Browne SM, Crozier I, Davey RT, Lane HC, Hensley LE, Follmann DA. Vector-Induced Humoral Responses After rVSV?G-ZEBOV-GP Immunization Identify Vaccinated Individuals and Correlate With Ebola Virus Glycoprotein Antibodies. J Infect Dis. 2025 Oct 15; 232(4):1004-1014.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|